Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mathilde Leclercq

Showing results (21-30 of 37) with videos related to

Pageof 4
Sort By:
Epilepsia|September 18, 2025
Extracellular vesicle microRNAs are biomarkers of focal epilepsy but not epilepsy-related respiratory dysfunctionSylvain Rheims, Hayet Kouchi, Florence Busato, et al.
Journal of Clinical Medicine|June 10, 2023
Behçet's Disease UveitisMorgane Joubert, Anne-Claire Desbois, Fanny Domont, et al.
The Journal of Rheumatology|March 1, 2023
Tocilizumab in Behçet Disease: A Multicenter Study of 30 PatientsMohamed-Yacine Khitri, Alessandra Bartoli, Georgina Maalouf, et al.
Clinical and Experimental Rheumatology|August 9, 2021
Prevalence and clinical features of COVID-19 in a large cohort of 199 patients with sarcoidosisAnne-Claire Desbois, Cindy Marques, Leila Lefèvre, et al.
Ocular Immunology and Inflammation|November 9, 2020
Prognosis Factors and Outcomes of Neuro-ophthalmologic SarcoidosisMathilde Leclercq, Thomas Sené, Catherine Chapelon-Abric, et al.
The British Journal of Ophthalmology|July 16, 2024
Methotrexate versus conventional disease-modifying antirheumatic drugs in the treatment of non-anterior sarcoidosis-associated uveitisMathilde Leclercq, Pascal Sève, Lucie Biard, et al.
Annals of the Rheumatic Diseases|November 13, 2020
Correspondence on 'Impact of COVID-19 pandemic on patients with large-vessels vasculitis in Italy: a monocentric survey'Cloé Comarmond, Mathilde Leclercq, Gaëlle Leroux, et al.
Ophthalmology|November 18, 2021
Anti-Tumor Necrosis Factor α versus Tocilizumab in the Treatment of Refractory Uveitic Macular Edema: A Multicenter Study from the French Uveitis NetworkMathilde Leclercq, Anaïs Andrillon, Georgina Maalouf, et al.
Epilepsy & Behavior : E&B|December 20, 2021
Coffee consumption and seizure frequency in patients with drug-resistant focal epilepsyJulie Bourgeois-Vionnet, Philippe Ryvlin, Mad-Hélénie Elsensohn, et al.
Epilepsia Open|April 28, 2025
Efficacy of naloxone in reducing hypoxemia and duration of immobility following focal to bilateral tonic-clonic seizuresSylvain Rheims, Fatima Chorfa, Véronique Michel, et al.
Pageof 4

Showing results (21-30 of 37) with videos related to

Sort By:
Pageof 4
Epilepsia|September 18, 2025
Extracellular vesicle microRNAs are biomarkers of focal epilepsy but not epilepsy-related respiratory dysfunctionSylvain Rheims, Hayet Kouchi, Florence Busato, et al.
Journal of Clinical Medicine|June 10, 2023
Behçet's Disease UveitisMorgane Joubert, Anne-Claire Desbois, Fanny Domont, et al.
The Journal of Rheumatology|March 1, 2023
Tocilizumab in Behçet Disease: A Multicenter Study of 30 PatientsMohamed-Yacine Khitri, Alessandra Bartoli, Georgina Maalouf, et al.
Clinical and Experimental Rheumatology|August 9, 2021
Prevalence and clinical features of COVID-19 in a large cohort of 199 patients with sarcoidosisAnne-Claire Desbois, Cindy Marques, Leila Lefèvre, et al.
Ocular Immunology and Inflammation|November 9, 2020
Prognosis Factors and Outcomes of Neuro-ophthalmologic SarcoidosisMathilde Leclercq, Thomas Sené, Catherine Chapelon-Abric, et al.
The British Journal of Ophthalmology|July 16, 2024
Methotrexate versus conventional disease-modifying antirheumatic drugs in the treatment of non-anterior sarcoidosis-associated uveitisMathilde Leclercq, Pascal Sève, Lucie Biard, et al.
Annals of the Rheumatic Diseases|November 13, 2020
Correspondence on 'Impact of COVID-19 pandemic on patients with large-vessels vasculitis in Italy: a monocentric survey'Cloé Comarmond, Mathilde Leclercq, Gaëlle Leroux, et al.
Ophthalmology|November 18, 2021
Anti-Tumor Necrosis Factor α versus Tocilizumab in the Treatment of Refractory Uveitic Macular Edema: A Multicenter Study from the French Uveitis NetworkMathilde Leclercq, Anaïs Andrillon, Georgina Maalouf, et al.
Epilepsy & Behavior : E&B|December 20, 2021
Coffee consumption and seizure frequency in patients with drug-resistant focal epilepsyJulie Bourgeois-Vionnet, Philippe Ryvlin, Mad-Hélénie Elsensohn, et al.
Epilepsia Open|April 28, 2025
Efficacy of naloxone in reducing hypoxemia and duration of immobility following focal to bilateral tonic-clonic seizuresSylvain Rheims, Fatima Chorfa, Véronique Michel, et al.
Pageof 4